Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib and Sirolimus in Metastatic Renal Cell Carcinoma
NCT00353301Phase 2Completed
- Sponsor
- University of Colorado Denver
- Start
- Jul 2006
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib, sirolimus in renal cell carcinoma (RCC), sponsored by University of Colorado Denver. Started Jul 2006; status: completed.
02
Drugs
erlotinibsirolimus
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00353301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00353301.